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Due to the limitation of current pharmacological therapeutic strategies, stem cell therapies have emerged as a viable option
for treating many incurable neurological disorders. Specifically, human pluripotent stem cell (hPSC)-derived neural progenitor
cells (hNPCs), a multipotent cell population that is capable of near indefinite expansion and subsequent differentiation into the
various cell types that comprise the central nervous system (CNS), could provide an unlimited source of cells for such cell-based
therapies. However the clinical application of these cells will require (i) defined, xeno-free conditions for their expansion and
neuronal differentiation and (ii) scalable culture systems that enable their expansion and neuronal differentiation in numbers
sufficient for regenerative medicine and drug screening purposes. Current extracellular matrix protein (ECMP)-based
substrates for the culture of hNPCs are expensive, difficult to isolate, subject to batch-to-batch variations, and, therefore,
unsuitable for clinical application of hNPCs. Using a high-throughput array-based screening approach, we identified a synthetic
polymer, poly(4-vinyl phenol) (P4VP), that supported the long-term proliferation and self-renewal of hNPCs. The hNPCs
cultured on P4VP maintained their characteristic morphology, expressed high levels of markers of multipotency, and retained
their ability to differentiate into neurons. Such chemically defined substrates will eliminate critical roadblocks for the
utilization of hNPCs for human neural regenerative repair, disease modeling, and drug discovery.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CCBY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).human embryonic stem cells [hESCs] and human inducedIntroduction
Several neurodegenerative diseases and neural-related disor-
ders are characterized by the damage to cells in the central
nervous system (CNS). Human neural progenitor cells (hNPCs)
derived from human pluripotent stem cells (hPSCs, including⁎ Corresponding author at: 501 E. Tyler Mall, ECG 334A, Tempe, AZ
85287, United States.
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).pluripotent stem cells [hiPSCs]) can proliferate extensively
and differentiate into all the neural lineages and supporting
cells (i.e. neurons, astrocytes, and oligodendrocytes) that
compromise the central nervous system (Chambers et al.,
2009; Elkabetz et al., 2008; Shin et al., 2006). As such, there is
great interest in the use of hNPCs for a variety of applications.
First, hNPCs provide a unique opportunity to explore complex
neural development processes in a simplified and accessible
system. For example, hNPCs can provide an unlimited source ofs is an open access article under the CC BY-NC-ND license
76 Y. Tsai et al.neurons that can be used for a multitude of research studies
ranging from cellular electrophysiology to protein biochemistry.
Second, hNPCs and their derivatives generated from patients
with genetic neural diseases can be used to provide important
insights into disease pathology, progression, and mechanism
(Marchetto et al., 2010; Imaizumi and Okano, 2013). Third, the
ability to generate large quantities of human neural cells will
enable the development of compounds and the screening of
potential drugs for neurotoxicity (Betts, 2010; Bosnjak, 2012;
Wilson et al., 2014). Lastly, because of the limited regener-
ative potential of the CNS, there is great promise for the use of
hNPCs in cell replacement therapies (Yuan et al., 2011;
Kakinohana et al.; Lu et al.; Hefferan et al., 2012). However,
the use of hNPCs for such applications requires the develop-
ment of efficacious and cost-effective defined culture systems
for their large-scale expansion and differentiation.
The growth and differentiation of hNPCs depend on
their microenvironment, including the chemical and physical
properties of the extracellular matrix (ECM). However, current
substrates used for hNPC expansion and differentiation, such as
laminin (LN), are expensive, difficult to isolate, vary between
lots, and contain xenogenic components which limit their use
for clinical applications. Moreover, it has been reported that the
heterogeneous composition of currently available matrices can
lead to variable hNPC expansion rates, non-homogenous hNPC
expansion, and inability of hNPCs to respond to differentiation
signals (Bouhon et al., 2006; Li et al.). These limitations are a
significant bottleneck in the clinical application of these cells
where large quantities of homogenous hNPC and neuronal
populations are required. In contrast, synthetic, polymer-based
substrates that are inexpensive and easily fabricated represent
a reliable alternative for the expansion and differentiation of
hNPCs. Polymeric biomaterials have been utilized as substrates
for the growth of a variety of adult stem cell types such as
hematopoietic (Bagley et al., 1999; Banu et al., 2001; Berrios et
al., 2001; Ehring et al., 2003) and mesenchymal stem cells
(Curran et al., 2006; Kotobuki et al., 2008; Zhao et al., 2006;
Fan et al., 2006; Richardson et al., 2008). More recently, we and
others have developed polymeric materials that support the in
vitro expansion of hPSCs in defined conditions (Villa-Diaz et al.,
2010; Brafman et al., 2010; Mei et al., 2010; Zhang et al., 2013).
However, polymeric materials as artificial matrices to support
the growth and differentiation of hNPCs have not been
developed.
In this study, we used a high-throughput screening ap-
proach to systematically screen a diverse library of synthetic
polymers for their ability to support hNPC growth. Using this
approach, we identified one polymer, poly(4-vinyl phenol)
(P4VP), that supported the long-term growth and multi-
potency of hNPCs. In addition, P4VP was able to support the
directed neuronal differentiation of hNPCs. This is the first
example of long-term culture and neuronal differentiation
of hNPCs on a chemically defined substrate free from
exogenous extracellular matrix proteins (ECMPs).Materials and methods
hNPC generation and culture
hNPCs were derived from HUES9, H9, HES3 and RiPSC (Warren
et al., 2010) hPSCs as previously described (Brafman, 2014).Briefly, to initiate neural differentiation, hPSCs were cultured
on Matrigel (BD Biosciences) in TeSRTM2 defined medium (Stem
Cell Technologies). Cells were then detached with treatment
with Accutase (Millipore) for 5 min and resuspended in neural
induction media [(1% N2/1% B27 without vitamin A/DMEM:F12),
50 ng/ml recombinant mouse Noggin (R&D Systems), 0.5 μM
Dorsomorphin (Tocris Bioscience)] and 5 μM Y-27632
(Stemgent). Next, 7.5 × 105 cells were pipetted to each well
of a 6-well ultra low attachment plates (Corning). The plates
were then placed on an orbital shaker set at 95 rpm in a 37 °C/
5% CO2 tissue culture incubator. The next day, the cells formed
spherical clusters (embryoid bodies [EBs]) and the media was
changed to neural inductionmedia. Themedia was subsequent-
ly changed every other day. After 5 days in suspension culture,
the EBs were then transferred to a 10 cm dish coated (3 × 6
wells per 10 cm dish) with growth factor reduced Matrigel (1:25
in KnockOut DMEM; BD Biosciences) for attachment. The plated
EBs were cultured in neural induction media for an additional
7 days. Neural rosettes were cut out by dissection under an
EVOS (Life Technologies) microscope. Dissected rosettes were
incubated in Accutase for 5 min and then triturated to single
cells with a 1 ml pipet. Rosettes were then plated onto
poly-L-ornithine (PLO; 10 μg/ml; Sigma) and mouse laminin
(LN; 5 μg/ml; Sigma) coated dishes at a density of
12,500 cells/cm2 in neural expansion media [(1% N2/1% B27
without vitamin A/DMEM:F12), 10 ng/ml mouse FGF2 (R&D
Systems), and 10 ng/ml mouse EGF2 (R&D Systems)]. For
routine maintenance, hNPCs were passaged onto PLO/
LN-coated plates at a density of 10,000 cells/cm2 in neural
expansion media.
Polymer array fabrication
Arrays of polymers were fabricated as previously de-
scribed (Brafman et al., 2010; Brafman et al., 2012). Briefly,
glass slides were cleaned, silanized, and then functionalized
with a polyacrylamide gel layer. Polymers were dissolved in
the appropriate solvents (PBS, DMSO, DMF, or toluene) at a
final concentration of 40 mg/ml. A list of polymers screened
is provided in Supplementary Table 1. Polymers 1–10 were
synthesized by free radical polymerization, polymers 11–80
were purchased from Sigma-Aldrich, and polymers 81–89
were purchased from PolySciences. A contact arrayer
(SpotBot® 2, Arrayit®) was used to print the polymers. The
printing conditions were a 1000 ms inking time and a 250 ms
stamping time. Each spot had a diameter of 150–200 μm and
neighboring spots were separated by a center-to-center
distance of 450 μm. Slides were inspected manually under a
light microscope for consistent and uniform polymer depo-
sition. LN (250 μg/ml) was spotted as control and served as
a reference to compare experiments from non-identical
arrays. Prior to their use, array slides were soaked in PBS
while being exposed to UVC germicidal radiation in a sterile
flow hood for 10 min.
Culturing of hNPCs on polymer arrays
hNPCs were passaged (1.0 × 106 cells per slide) directly onto
the slides and allowed to settle on the spots for 24 h prior to
rinsing with neural expansion media 3 times to remove
residual cells and debris. hNPCs were cultured on the arrays
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growth factors were replenished daily.
Array slide staining, imaging, and quantification.
After 7 days of culture, the arrays were fixed for 15 min
at room temperature (RT) with fresh paraformaldeyde
(4% (w/v)). The arrays were washed twice with PBS and
permeabilized with 0.2% (v/v) Triton-X-100 in PBS for 20 min
at 4 °C. Cultures were then washed twice with PBS. Primary
antibodies were incubated overnight at 4 °C and then
washed twice with PBS at RT. Secondary antibodies were
incubated at RT for 1 h. Antibodies used are listed in
Supplementary Table S5. Nucleic acids were stained for
DNA with Hoechst 33342 (2 μg/ml; Life Technologies) for
5 min at room temperature. Arrays were imaged using a
CellInsightTM CX5 (Thermo Scientific) automated high-
content screening platform. The system was programmed
to visit each spot on the array, perform autofocus, and
acquire Hoechst, FITC (SOX1), and Cy5 (NESTIN) images. Cell
counts and stain intensities were measured using Thermo
ScientificTM HCS StudioTM 2.0 Software using the built-in
object identification and cell intensity algorithms.
hNPC expansion and neuronal differentiation on
polymer-coated slides.
In order to coat the polyacrylamide-coated glass slides
with the ‘hit’ polymers, 120 μl of each polymer (40 mg/ml)
was placed dropwise into the center of the glass slide. A
coverslip was placed on top of the glass slide to allow for
uniform coating of the polymer. The polymer-coated slide
was incubated for 1 h at 37 °C. The coverslip was then
removed and the slide was washed 3 times with PBS prior to
use. The presence of coated polymer was verified by
FTIR-ATR (Supplementary Fig. 1). FTIR spectra were ac-
quired on a Nicolet 6700 with Smart-iTR using a N2 purged
sample chamber. The acquisition parameters were: 128 scan
and 4 cm−1 spectra resolution.
For hNPC expansion studies on polymer-coated slides,
hNPCs were passaged (1.2 × 106 cells per slide) directly from
PLO/LN plates onto the polymer-coated slides. hNPCs were
maintained in neural expansion media. Culture media and
growth factors were replenished daily. hNPCs were routinely
passaged onto new polymer-coated slides every 5 days. For
hNPC neuronal differentiation studies on polymer-coated
slides, hNPCs were cultured in neuronal differentiation
media [(0.5% N2/0.5% B27 without vitamin A/DMEM:F12),
20 ng/ml BDNF (R&D Systems), 20 ng/ml GDNF (R&D
Systems), 1 μM DAPT (Tocris Bioscience), and 0.5 mM,
dibutyrl-cAMP (db-cAMP; Sigma)] for 4 weeks.
Quantitative PCR (QPCR)
RNA was isolated from cells using the NucleoSpin® RNA Kit
(Clontech). Reverse transcription was performed with qScript
cDNA Supermix (Quanta Biosciences). Quantitative PCR was
carried out using TaqMan® Assays or SYBR® green dye on a
BioRad CFX96 TouchTM Real-Time PCR Detection System. For
the QPCR experiments run with TaqMan® Assays a 10 min
gradient to 95 °C followed by 40 cycles at 95 °C for 5 s and
60 °C for 30 s min was used. For QPCR experiments run withSYBR® green dye, a 2 min gradient to 95 °C followed by
40 cycles at 95 °C for 15 s and 60 °C for 1 min was used. The
list of TaqMan® assays and primer sequences used is provided
in Supplementary Table S4. Gene expression was normalized
to 18S rRNA levels. Delta Ct values were calculated as
Cttarget − Ct18s. All experiments were performed with three
technical replicates. Relative fold changes in gene expression
were calculated using the 2−ΔΔCt method (VanGuilder et al.,
2008). Data are presented as the average of the biological
replicates ± standard error of the mean (SEM).
Immunofluorescence
Cultures were gently washed twice with staining buffer
(PBS w/1% (w/v) BSA) prior to fixation. Cultures were then
fixed for 15 min at room temperature (RT) with fresh
paraformaldeyde (4% (w/v)). The cultures were washed
twice with staining buffer and permeabilized with 0.2% (v/v)
Triton-X-100 in stain buffer for 20 min at 4 °C. Cultures
were then washed twice with staining buffer. Primary
antibodies were incubated overnight at 4 °C and then
washed twice with stain buffer at RT. Secondary antibodies
were incubated at RT for 1 h. Antibodies used are listed in
Supplementary Table S5. Nucleic acids were stained for DNA
with Hoechst 33342 (2 μg/ml; Life Technologies) for 5 min at
room temperature. Imaging was performed using an auto-
mated confocal microscope (Olympus Fluoview 1000 with
motorized stage). Quantification of images was performed
by counting a minimum of 9 fields at 20× magnification.
Image quantification of the data is presented as the average
of these fields ± standard deviation (SD). Cell length and cell
area measurements were conducted on 45 cells from 3 fields
at 20× magnification at each time point using Image J.
Population doubling time
Population doubling time of hNPCs cultured on LN and P4VP
substrates was calculated using the following equation: PDT
(h) = (T2 − T1) / (3.32 * [log(N2) − log(N1)]).
Flow cytometry
Cells were dissociated with Accutase for 5 min at 37 °C,
triturated, and passed through a 40 μm cell strainer. Cells
were then washed twice with FACS buffer (PBS, 10 mM
EDTA, and 2% FBS) and resuspended at a maximum con-
centration of 5 × 106 cells per 100 μl. One test volume of
antibody was added for each 100 μl cell suspension (Supple-
mentary Table S5). Cells were stained for 30 min on ice,
washed, and resuspended in stain buffer. Cells were
analyzed and sorted with a FACSCanto (BD Biosciences).
Flow cytometry data was analyzed with FACSDiva software
(BD Biosciences). Isotype negative controls are listed in
Supplementary Table S5.
Results
Polymer microarray screen with hNPCs
We have previously described the development of a high-
throughput microarray technology for the systematic
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cell fate (Brafman et al., 2010). Briefly, we used a contact
DNA microarray spotting instrument to deposit nanoliter
amounts of polymer solutions onto glass microscope slides
coated with a layer of acrylamide gel (~10 μm thick). The
spotted polymer chains are mechanically interlocked with the
underlying acrylamide gel and anchored in place after solvent
evaporation. Each polymer spot is 150–200 μm in diameter
with a center-to-center distance of 450 μm. Cells are globally
seeded onto the arrays and due to the non-fouling nature of
the acrylamide hydrogel cells only adhere to sites of polymer
deposition. As we have previously shown (Brafman et al.,
2010; Brafman et al., 2012; Brafman et al., 2009a; Brafman et
al., 2013; Brafman et al., 2009b), paracrine signaling between
neighboring spots is limited and each spot can be treated an
independent ‘well’. Combined with high-content automated
microscopy which allows for quantitative single-cell analysis,
this technology can be used to screen the effect of thousands
of unique polymer compositions on the fate of any cell type of
interest on a single microscope slide.Figure 1 High-throughput screening of polymers for hNPC growth
seeding onto the array, hNPCs were cultured on PLO/LN substrates
maintenance of hNPC multipotency markers SOX1 and NESTIN. hNPC
automated high-content microscopy. hNPCs were assessed for their
phenotype (SOX1 and NESTIN). (B) Screening paradigm used for ident
maintenance of multipotency.We utilized this array technology to identify polymers
that support hNPC adhesion, growth, and multipotency
(Fig. 1A). hNPCs were derived from hPSCs and expanded on
laminin (LN)-coated substrates in the presence of bFGF and
EGF as previously described (Brafman, 2014). Prior to seed-
ing onto the array, expanded hNPCs were routinely assessed
for their characteristic morphology and maintenance of
markers of hNPC multipotency such as SOX1 and NESTIN
(Fig. 1A). Biomaterials often mediate cell adhesion through
integrin-mediated interactions between the cells and extra-
cellular matrix proteins (ECMPs) that have been absorbed
from the surrounding media (Shin et al., 2003). To eliminate
the undefined absorption of these soluble ECMPs, we per-
formed all of our screens in the presence of a medium (see
Materials and methods) which contained no soluble ECMPs.
As such, any observed interaction between a specific poly-
mer and hNPCs would be independent of exogenously ab-
sorbed soluble ECMPs.
To seed the polymer arrays, hNPCs were enzymatically
dissociated into single cells, and cell suspensions were. (A) Schematic representation of polymer array assay. Prior to
and routinely assessed for their characteristic morphology and
s were cultured on the polymer arrays for 7 days and imaged by
proliferation (Hoechst) and maintenance of a multipotent hNPC
ification of polymers that support hNPC attachment, growth, and
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quently, the medium was replaced to remove non-adhering
cells and debris. Seeding the slide with 1.0 × 106 hNPCs
allowed for the attachment of 5–10 cells per spot and
provided sufficient area for growth. hNPCs were allowed to
grow for 7 days in the presence of FGF2 and EGF, which
maintain hNPCs in a proliferative, multipotent state. After
7 days, the cells were stained for the hNPC multipotency
markers SOX1 and NESTIN and high-content imaging was
used to count cells and measure SOX1 and NESTIN intensities
at a single-cell level (Fig. 1A).
Using the polymer array technology, we screened a li-
brary of diverse polymers with varying functional groups,
charge density, hydrophobicity, and molecular weight
(Supplemental Table 1). For instance, since heparin modu-
lates the activity of bFGF and EGF (Burgess and Maciag,
1989; Bellosta et al., 2001), growth factors that play crucial
roles in self-renewal of NPCs, this library contains several
heparin-mimicking polymers with sulfate and carboxyl func-
tional groups. Our approach consisted of two rounds of
screening, resulting in the identification of several ‘hits’,
which we subsequently scaled-up and assessed for their
ability to support long-term hNPC expansion (Fig. 1B). In the
first round of screening, each polymer was tested individu-
ally at a single concentration (40 mg/ml). As a control we
used LN, which supports the adhesion and growth of hNPCs.
After 7 days, cells were stained with a DNA stain (Hoechst)
and the number of cells per spot was counted by automated
high-content imaging (Fig. 2A and Supplemental Table 2).
For the first round of screening, a ‘hit’ was defined as a
polymer supporting the average cell number (across 5
replicate spots) ≥75% of the average cell number on the
control LN spots. By this criterion, we identified 17 polymer
‘hits’ in our first round of screening (Fig. 2B). In the second
round of screening, these top ‘hits’ were rescreened and
assessed for their ability to support the short-term growth
(determined by cell number) and multipotency (determined
by SOX1 and NESTIN expression) of hNPCs (Fig. 2C and
Supplemental Table 3). For the second round of screening, a
‘hit’ was defined as a polymer supporting the average cell
number and SOX1/NESTIN expression (across 8 replicate
spots) ≥90% of hNPCs grown on control LN spots (Fig. 2D).
From this second screen, 4 polymers demonstrated the
ability to support growth and maintenance of multipotency
at similar levels as LN (Fig. 2E).Long-term culture of hNPCs on defined
polymer substrate
In order to investigate the scalability of the 4 ‘hit’
polymers physicochemical properties and ability to sup-
port long-term hNPC growth, acrylamide gel-coated slides
were coated with the ‘hit’ polymers by thermal evapora-
tion (see Materials and methods). The presence of polymer
coating was verified by FTIR-ATR (Supplemental Fig. 1).
hNPCs were enzymatically detached from LN-coated
substrates and passaged onto the polymer-coated slides.
Detachment or spontaneous differentiation, as indicated
by changes in morphology was observed on all the ‘hit’
polymers with the exception of poly(4-vinyl phenol) (P4VP;
Fig. 3A and B).Next, we tested the ability of P4VP to support hNPC
expansion over 10 passages (~50 days). hNPCs cultured on
P4VP substrates maintained their characteristic morphology
over the 10 passages (Fig. 4A). Additionally, hNPCs cultured
on PV4P exhibited similar growth dynamics (Fig. 4B) and
doubling time (Fig. 4C) to cells cultured on LN substrates.
Moreover, the rate of cell growth on P4VP substrates
remained stable during the 10 passages (Fig. 4D). In fact,
cell counts taken at each passage revealed that 1 × 106
hNPCs could theoretically be expanded to 1 × 109 hNPCs
over 10 passages (Fig. 4D). Maintenance of a hNPC pheno-
type was assessed by quantitative RT-PCR for hNPC makers
SOX1, SOX2, and NESTIN (Fig. 4E). hNPCs grown on P4VP
maintained expression of these markers at levels similar to
that of cells grown on LN substrates. Along similar lines,
flow cytometry (Fig. 4F) and immunostaining (Fig. 4G)
revealed that hNPCs cultured on P4VP-coated substrates for
10 passages continued to express high levels of the hNPC
markers SOX1, SOX2, and NESTIN. Together, these results
demonstrate the ability of P4VP to support the long-term
culture of hNPCs.
Because P4VP could support the long-term growth of
hNPCs, we wanted determine if P4VP could be used as
a matrix for the derivation of hNPCs. To that end, we plated
EBs directly onto LN- and P4VP-coated substrates. In
comparison to EBs plated onto Matrigel-coated plates, EBs
plated directly onto LN or P4VP matrices failed to form
neuroepithelial-like rosettes (Supplemental Fig. 2A). Simi-
larly, while dissected rosettes plated onto LN substrates
resulted in the formation of hNPCs, rosettes replated on
P4VP-coated surfaces did not result in the generation of
hNPCs. However, dissociated rosettes initially replated
onto LN substrates and then subsequently transferred to
P4VP substrates resulted in the formation of cells represen-
tative of hNPCs (Supplemental Fig. 2B). In fact, hNPCs
continually cultured on PLO/LN or transitioned to P4VP
substrates displayed similar morphology (Supplemental
Fig. 2B), growth rate (Supplemental Fig. 2C and D), and
expression of hNPCmarkers SOX2 and NESTIN (Supplemental
Fig. 2E).Neuronal differentiation of hNPCs on defined
polymer substrate
Because of the dynamic nature of cell–substrate interac-
tions during stem cell differentiation (Brafman et al., 2013;
Marthiens et al., 2010; Dalby et al., 2014; Wojcik-Stanaszek
et al., 2011), the same synthetic substrate may not be suit-
able for both hNPC expansion and neuronal differentiation.
To that end, we assessed the ability of P4VP to support the
directed neuronal differentiation of hNPCs. Specifically,
hNPCs were seeded onto P4VP substrates and differentiated
to neurons through the withdrawal of bFGF and EGF, and
addition of neuronal inducing factors brain-BDNF, GDNF,
db-cAMP, and the Notch inhibitor DAPT. After 4 weeks in the
presence of neuronal induction factors, cells cultured on
P4VP substrates acquired a neuronal morphology (Fig. 5A).
Immunofluorescence revealed that a high percentage of the
cells stained positive for the pan-neuronal markers NeuN
(Fig. 5B), neurofilament-68 (NF-L; Fig. 5C), microtubule-
associated protein 2 (MAP2; Fig. 5D) and β-Tubulin-III (β3T;
80 Y. Tsai et al.Fig. 5E). In fact, quantitative RT-PCR revealed that cells
differentiated on P4VP expressed higher levels of MAP2 and
β3T than those differentiated on LN substrates (Fig. 5F).
Along similar lines, neuronal differentiation of NPCs on
P4VP resulted in a higher number of MAP2 and β3T positiveneurons than NPCs differentiated on LN substrates (Fig. 5G).
Collectively, this data indicates that in addition to
supporting the long-term expansion of hNPCs that P4VP
can also serve as an effective neuronal differentiation
matrix.
Figure 3 Scalability of ‘hits’ identified from polymer array screen. (A) Phase contrast images of hNPCs cultured on glass slides
coated with laminin (LN) and the 4 ‘hit’ polymers: poly(4-vinyl phenol) [P4VP], poly(azelaic anhydride) [PAzA], poly(styrene-co-allyl
alcohol) [PS-co-AA], and poly(styrene-maleic acid) [PSMA]. (B) Cell count of hNPCs cultured on the ‘hit’ polymer- and LN-coated slides
for 5 days. Quantification of images was performed by counting a minimum of 9 fields at 20× magnification. Image quantification of
the data is presented as the average of these fields ± standard deviation (SD). Cell counts on polymers were compared to cell counts
on LN controls using Student's t-test. ***p b 0.001, N.S. = not statistically significant.
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P4VP substrates
To elucidate the mechanism of hNPC attachment and growth
on P4VP substrates, we performed time-lapse imaging of
initial hNPC attachment on P4VP and LN-coated substrates
(Fig. 6A). Quantitative analysis of the dynamics of cell length
(Fig. 6B) and cell area (Fig. 6C) revealed that initial hNPC
attachment and spreading significantly differed on P4VP and
LN substrates. While hNPCs immediately adhered and spread
on LN substrates, cells on P4VP remained rounded for several
hours prior to achieving a similar level of adhesion and
spreading as hNPCs cultured on LN substrates.Figure 2 Analysis of hNPCs on polymer arrays. (A) Heat map for the
for each polymer (row) on each replicate spot (column) has been qu
on the control LN spots. The rows are arranged from high to low based
denotes the polymers with an average cell number ≥75% of the ave
number on the 17 ‘hit’ polymers and LN control spots (mean ± SEM
screening in which the number and SOX1/NESTIN expression of cells
quantified. Values were normalized to the average values of cells o
based on the average value of all three parameters among replicate
cell number and NESTIN/SOX1 expression ≥90% of hNPCs grown on c
intensities of hNPCs on the 4 ‘hit’ polymers and LN control spots (m
representative immunofluorescent images of hNPCs on ‘hit’ polymeTo determine if these differences in cell spreading rates
could be explained by differences in endogenous ECMP
expression, we analyzed the kinetics of the expression levels
of genes encoding several ECMPs that have previously been
shown to influence hNPC fate (Li et al., 2012; Ma et al.,
2008; Gil et al., 2009; Li et al., 2014) including collagen I
(COL1), collagen IV (COL4), fibronectin (FN), laminin (LN),
and vitronectin (VTN) (Fig. 6D). The expression levels of
endogenous ECMPs of hNPCs cultured on LN substrates
peaked upon initial adhesion (1 h) but quickly decreased
upon subsequent culture. On the other hand, hNPCs cultured
on P4VP showed prolonged expression of endogenous ECMPs
with expression decreasing only after 12 h of culture. Thisfirst round of polymer array screening in which the cell number
antified. Values were normalized to the average number of cells
on the average value among replicate spots (n = 5). A black box
rage cell number on the control LN spots. (B) The average cell
, n = 8). (C) Heat map for the second round of polymer array
on each polymer (row) on each replicate spot (column) has been
n the control LN spots. The rows are arranged from high to low
spots (n = 8). A black box denotes the polymers with an average
ontrol LN spots. (D) The average cell number and NESTIN/SOX1
ean ± SEM, n = 8). (E) Chemical structures of ‘hit’ polymers and
r spots.
Figure 4 Long-term expansion of hNPCs on P4VP. (A) Phase contrast images of hNPCs cultured on P4VP for 10 passages. (B) Growth
rate of hNPCs on P4VP and LN (mean ± SEM, n = 3). (C) Doubling time of hNPCs cultured on P4VP and LN (mean ± SEM, n = 3).
(D) hNPCs were cultured on P4VP for 10 passages and cell growth was analyzed by cell count at each passage (mean ± SEM, n = 3).
(E) Gene expression analysis of SOX1, SOX2, and NESTIN of hNPCs cultured on P4VP and LN for 10 passages (mean ± SEM, n = 3).
Populations were compared using Student's t-test. N.S. = not statistically significant. (F) Flow cytometry and (G) immunofluorescent
analysis of hNPCs cultured on P4VP for 10 passages. Isotype controls used are listed in Supplementary Table 5.
82 Y. Tsai et al.time point coincided with the time point at which cells
cultured on P4VP showed a similar level of spreading as
hNPCs cultured on LN substrates.
We also measured the expression levels of the integrin cell
surface proteins known to mediate cell adhesion to these
ECMPs (Humphries et al., 2006) (Fig. 6E). Similar to the
dynamics of the endogenous ECMP expression, the expression
levels of α-integrins 1–3, 5 and ν, and β integrins 1, 3, and 5
of hNPCs cultured on LN peaked upon initial adhesion (1 h)
but rapidly declined upon subsequent culture. In contrast,
peak expression of these integrins in hNPCs cultured on P4VP
substrates was delayed and did not significantly decrease
until after 12 h in culture. Together, these differences in cell
spreading and attachment as well as endogenous ECMP and
integrin expression dynamics suggest a possible mechanism
by which initial hNPC attachment on P4VP is supported
through an integrin-ECMP independent interaction. In turn,
this temporary interaction allows the cells to secrete their
own ECMPs and assemble a microenvironment to support
further spreading and adhesion.
Discussion
The use of hNPCs for disease modeling, drug screening, or
cell therapies requires the development of efficacious andcost-effective defined substrates for their expansion and
neuronal differentiation. In this study, we employed an
unbiased, high-throughput screening approach to system-
atically screen a diverse library of chemically defined poly-
mers for the in vitro expansion and neuronal differentiation
of hNPCs. Although most of the polymers screened were
unable to support the long-term expansion of hNPCs, we
identified one polymer, P4VP, which was able to support the
long-term culture of hNPCs over multiple passages. In fact,
hNPCs cultured on these synthetic substrates maintained
their characteristic morphology while growing at a similar
rate and expressing similar levels of multipotent NPC
markers as cells cultured on LN substrates. Additionally, in
the presence of neuronal inducing factors, hNPCs efficiently
differentiated to cells representative of neurons.
The mechanism by which P4VP supports hNPC expansion
is not entirely clear. Live cell imaging revealed that hNPCs
cultured on P4VP had delayed cell attachment and spread-
ing kinetics. Additionally, we found that hNPCs cultured on
P4VP showed increased and prolonged expression of several
endogenous ECMPs and the integrins known to mediate cell
attachment to these specific ECMPs. Because the media
used for hNPC culture was free of exogenous ECMPs, we
speculate that P4VP fosters initial hNPC adhesion in an
ECMP-independent manner, possibly through electrostatic
Figure 5 Neuronal differentiation of hNPCs on P4VP. (A) Phase contrast images of neurons differentiated on P4VP. (B) Phase
contrast and immunofluorescence of mature neuronal markers NeuN, (C) NF-L, (D) MAP2 and (E) B3T in neuronal cultures
differentiated on P4VP. (F) Gene expression analysis of MAP2 and B3T of neuronal cultures differentiated on P4VP and LN substrates
(mean ± SEM, n = 3). Populations were compared using Student's t-test. * p b 0.05, **p b 0.01. (G) Quantification of the number of
MAP2- and B3T-positive neurons generated on P4VP and LN substrates. Quantification of images was performed by counting a
minimum of 9 fields at 20× magnification. Image quantification of the data is presented as the average of these fields ± standard
deviation (SD). Populations were compared using Student's t-test. ***p b 0.001.
83Defined substrate for hNPC expansioninteractions between the cells and the substrate (Smetana
et al., 1992; Kirby et al., 2003; Lampin et al., 1997; Lofti et
al., 2013). Subsequently, the cells secrete their own ECMPs,
which delays attachment and spreading, but ultimately
provides a suitable microenvironment for cell attachment
and continued growth.
Although P4VP could support the expansion and differ-
entiation of hNPCs, it did not serve as a robust substrate
for the derivation of hNPCs. Specifically, unlike EBs plated
onto Matrigel-coated plates which spread out and formed
neuroepithelial-like rosettes, EBs plated directly onto P4VP-
or LN-coated substrates failed to form rosette-like struc-
tures. Along similar lines, while dissected rosettes generated
on Matrigel-coated plates led to the formation of hNPCs
upon replating on LN substrates, rosettes plated on P4VP-
coated surfaces did not result in the generation of cells
representative of hNPCs. However, dissociated rosettes that
were initially replated onto LN substrates and then subse-
quently transferred to P4VP substrates led to the generation
of cells representative of hNPCs. This suggests that hNPCs
may require a brief transition period in which dissected
rosettes need to be initially cultured on LN substrates after
which cells can be transitioned to P4VP substrates. In the
future, polymer array screens can be performed to identify
such synthetic substrates that directly support the deriva-
tion of hNPCs.
Interestingly, we found that neuronal differentiation of
hNPCs was significantly enhanced on P4VP compared to cells
differentiated on LN-coated culture surfaces. During in vivoneural development, the ECM undergoes dynamic changes
in response to soluble signaling molecules to regulate cell
proliferation, migration, and differentiation (Pavlov et al.,
2004; Barros et al., 2010; Wade et al., 2014). Along similar
lines, several in vitro studies have shown that ESC-derived
NPCs have specific substrate requirements to promote self-
renewal versus those needed to instruct neuronal specifi-
cation (Ma et al., 2008; Goetz et al., 2006 ). As such, ECMPs,
such as LN, have distinct and temporally specific effects
during ESC-derived NPC expansion and neuronal differenti-
ation (Ma et al., 2008; Goetz et al., 2006). Because cell–
substrate interactions change as stem cells shift from a state
of self-renewal to one of differentiation, we speculate that
P4VP provides a more permissive environment in which hNPCs
can respond to the exogenous soluble signaling microenviron-
ment and synthesize the necessary ECMP environment needed
for self-renewal or neuronal differentiation.
Arrays of polymers have been used by several groups as a
high-throughput means to develop polymer-based matrices
that support the self-renewal, proliferation, and differenti-
ation of a variety of stem cell types (Brafman et al., 2010;
Anderson et al., 2004; Hansen et al., 2014). Moreover, such
technologies have been successfully used to identify specific
biomaterial properties that precisely direct stem cell fate
(Mei et al., 2010). In one such study, it was demonstrated
that specific chemical functional groups could be used to
direct the differentiation of human mesenchymal stem cells
into either osteoblasts or adipocytes (Benoit et al., 2008).
The future clinical application of hNPCs for the study and
Figure 6 hNPCs cultured on P4VP demonstrate delayed cell attachment and spreading kinetics. (A) Phase contrast images of hNPCs
on P4VP and LN at various time points after initial cell seeding. (B) Cell length and (C) cell area were measured on 45 cells from 3
fields at 20× magnification at each time point using Image J (error bars = SD). Populations were compared using Student's t-test.
*p b 0.05, **p b 0.01, ***p b 0.001. Gene expression analysis of (D) endogenous ECMPs and (E) integrins of hNPCs cultured on P4VP and
LN at various time points after initial cell seeding. The data is displayed in a heat map where black corresponds to minimum
expression levels and red corresponds to maximum levels. For each gene analyzed, the expression levels were normalized to the
sample with the highest expression level.
84 Y. Tsai et al.treatment of neurodegenerative disorders will require a
similar ability to direct their differentiation into certain
fates such as regionally specific neuronal subtypes (Liu and
Zhang, 2011). For example, the generation of basal fore-
brain cholinergic neurons from hNPCs would aid in under-
standing the mechanisms of Alzheimer's disease (Duan et al.,
2014), while hNPC-derived spinal cord motor neurons have
the potential to treat spinal cord injuries and motor neuron
diseases such as amyotrophic lateral sclerosis (Qu et al.,
2014). In the future, unbiased, high-throughput screening
approaches, such as the one described in this study, com-
bined with high-throughput surface characterization and
regression models (Algahtani et al., 2014), will be useful to
engineer synthetic substrates with precise physicochemical
properties to precisely direct hNPCs towards these neuronal
subtypes.
Several groups have reported the culture and differenti-
ation of fetal or adult neural stem cells (NSCs) on polymer-
based substrates (Park et al., 2014; Little et al., 2008; Bhang
et al., 2007; Lundin et al., 2011; Saha et al., 2007). It is
important to point out that the NSCs used in these studies,
which can be isolated from numerous species and various
regions in the fetal and adult nervous system, are biologi-
cally and developmentally distinct from the hNPCs used in
this study (Kornblum, 2007; Temple, 2001). Specifically, the
differentiation potential and, thereby, the therapeutic ap-
plication of NSCs is much more limited than hNPCs, whichcan differentiate into all the neural lineages (i.e. neurons,
astrocytes, and oligodendrocytes) that compromise the cen-
tral nervous system (CNS) (Chambers et al., 2009; Elkabetz
et al., 2008; Shin et al., 2006). Because of these inherent
biological differences in NSCs and hNPCs, it is unclear if
these substrates that have been previously used for the
growth and differentiation of NSCs would have similar
efficacy if used with hNPCs. To our knowledge, the synthetic
matrix developed in this study is the first demonstration of
the use of a defined polymer-based substrate for the culture
and differentiation of hNPCs.
In order to have a sufficient number of hNPCs for re-
generative medicine and drug screening, efficient methods
for their large-scale expansion and differentiation need to
be developed. In fact, cell doses for stem cell-based neural
therapies have been reported in excess of 6 billion cells per
patient (Bretzner et al., 2011; Schwartz et al., 2012; Chen
et al., 2013). Although in this study theoretical calcula-
tions suggested that 1 × 106 hNPCs cultured on P4VP could
be expanded up to 1 × 109 cells in 10 passages (~50 days),
practical expansion and differentiation of hNPCs to these
numbers are not feasible with current 2D culture systems.
Alternatively, microcarriers (MCs), which provide a high-
surface area to volume ratio, enable high density cell expan-
sion and scale-up in stirred bioreactors (Reuveny, 1990; Sart
et al., 2013). Recently, the use of protein-coated MCs in
stirred suspension bioreactors has been reported for the
85Defined substrate for hNPC expansionexpansion of several hPSC lines and their derivatives (Sart
et al., 2013; Fan et al., 2013; Ting et al., 2014). In the
future, the culture of hNPCs on polymer-coated MCs in
suspension bioreactors may enable their expansion and
differentiation to the numbers required for regenerative
medicine purposes.Conclusions
In this study, we used a high-throughput screening process to
identify a synthetic polymer, P4VP, which can support the
long-term self-renewal and proliferation of hNPCs at a similar
level to cells cultured on purified ECMPs. Moreover, neuronal
differentiation of hNPCswasmore efficient on P4VP substrates
than these traditional ECMP-based substrates. P4VP is chem-
ically defined and available off-the-shelf, thus overcoming the
limitations associated with culture on purified ECMPs. Overall,
the polymeric biomaterial developed in this study offers a
cost-effective, scalable, and robust platform to support the in
vitro expansion and neuronal differentiation of hNPCs to the
quantities needed for disease modeling, drug screening, and
cell-based therapies.
Supplementary data to this article can be found online at
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